Flóra Jozefíková
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Flóra Jozefíková has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Jan Moncol
Department of Inorganic Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava SK-81237, Slovakia
4 shared publications - Jindra Valentová
Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov 10, 832 32 Bratislava, Slovakia
3 shared publications Miroslava Puchoňová
Department of Inorganic Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 812 37 Bratislava, Slovakia
3 shared publications- Barbora Svitková
Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia
2 shared publications Jindra Valentová
Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Odbojárov 10, 832 32 Bratislava, Slovakia
2 shared publications- Lucia Lintnerová
Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, 832 32 Bratislava, Slovakia
2 shared publications
Latest Publications
- Open Access
- 27 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8650
Reduced Schiff Base Copper(II) Complexes Derived from 2-, 3-, and 4-Methoxybenzylamine: DNA Binding and Cleavage, BSA Binding, Cytotoxic and SOD Mimetic Properties
A series of reduced Schiff base ligands derived from salicylaldehyde (1) and methoxybenzylamines (2a–c) were prepared and used to prepare three copper(II) complexes, 5a (2-methoxyderivative), 5b (3-methoxyderivative), and 5c (4-methoxyderivative). They were characterized by spectral methods and X-ray crystallography. The complexes showed DNA cleavage activity, with 30% cleavage at 3 × 10−3 M and up to 94.5% at 5 × 10−3 M. Absorption titration studies with ct-DNA and EB-DNA displacement methods revealed strong binding of the prepared complexes, with complexes 5b and 5c favored. Viscosity measurements and thermal degradation of DNA studies indicate DNA groove binding. All complexes exhibit a moderately strong binding affinity to serum albumin. The complexes performed very well in the resazurin assay monitoring mitochondrial activity, with significant cytotoxic effects (around 95% already at 1 × 10−4 M). The MTT assay confirmed the complexes’ cytotoxicity against cancer cell lines (A549, HepG2) compared with HEL fibroblasts. All complexes showed remarkable selectivity for HepG2 cells, with selectivity indices (HEL vs. HepG2) up to 3.05 for complex 5a, and complex 5b achieved the lowest IC50 (33.0 ± 5.3 μM) against HepG2 cells. From a regioisomerism perspective, complex 5a outperformed the others in DNA cleavage; complex 5b, with the 3-methoxy group, showed the most interesting cytotoxicity results, and both complexes 5b and 5c showed good DNA-binding properties.
- 27 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8650
Open AccessReduced Schiff Base Copper(II) Complexes Derived from 2-, 3-, and 4-Methoxybenzylamine: DNA Binding and Cleavage, BSA Binding, Cytotoxic and SOD Mimetic Properties
A series of reduced Schiff base ligands derived from salicylaldehyde (1) and methoxybenzylamines (2a–c) were prepared and used to prepare three copper(II) complexes, 5a (2-methoxyderivative), 5b (3-methoxyderivative), and 5c (4-methoxyderivative). They were characterized by spectral methods and X-ray crystallography. The complexes showed DNA cleavage activity, with 30% cleavage at 3 × 10−3 M and up to 94.5% at 5 × 10−3 M. Absorption titration studies with ct-DNA and EB-DNA displacement methods revealed strong binding of the prepared complexes, with complexes 5b and 5c favored. Viscosity measurements and thermal degradation of DNA studies indicate DNA groove binding. All complexes exhibit a moderately strong binding affinity to serum albumin. The complexes performed very well in the resazurin assay monitoring mitochondrial activity, with significant cytotoxic effects (around 95% already at 1 × 10−4 M). The MTT assay confirmed the complexes’ cytotoxicity against cancer cell lines (A549, HepG2) compared with HEL fibroblasts. All complexes showed remarkable selectivity for HepG2 cells, with selectivity indices (HEL vs. HepG2) up to 3.05 for complex 5a, and complex 5b achieved the lowest IC50 (33.0 ± 5.3 μM) against HepG2 cells. From a regioisomerism perspective, complex 5a outperformed the others in DNA cleavage; complex 5b, with the 3-methoxy group, showed the most interesting cytotoxicity results, and both complexes 5b and 5c showed good DNA-binding properties.
- Open Access
Synthesis, Structure, DNA/BSA Binding, DNA Cleaving, Cytotoxic and SOD Mimetic Activities of Copper(II) Complexes Derived from Methoxybenzylamine Schiff Base Ligands
Schiff base ligands prepared from salicylaldehyde and 2-, 3- and 4-methoxybenzylamine were used to prepare copper(II) complexes, characterized by spectral methods, elemental analysis and X-ray crystallography in the case of complex 4a derived from 2-methoxybenzylamine. The DNA cleavage activity of the prepared complexes was exceptional, with best activities of over 95% one-strand cleavage for 4c at 3 mM and full double-strand cleavage for complex 4a at 5 mM. Absorption titration studies with ct-DNA revealed good binding constants (at 105 M−1) with a decrease of up to 56% light absorption. Meanwhile, the EB–DNA displacement method and viscosity studies revealed groove binding as a possible binding mode. For BSA binding studies, all three complexes showed KBSA values in the optimal range for reversible BSA binding (104 M−1). The copper(II) complexes showed significant cytotoxic effects (67–96% at 1 mM) in mitochondrial activity monitoring assays. Cytotoxicity was confirmed against cancer cell lines (A549 and HepG2) and HEL cells. The complexes 4a and 4c exhibited high activity against HepG2 cancer cells (IC50 < 22 μM), comparable to cisplatin. The radical scavenging activity was determined by the INT method with the best IC50 for 4c (189 ± 11 μM). Overall, complexes 4a and 4c with a methoxy group in the ortho and para positions show high potential in most determined activities, but mainly as DNA cleavers and as cytotoxic agents with selectivity against HepG2 cells.
Open AccessSynthesis, Structure, DNA/BSA Binding, DNA Cleaving, Cytotoxic and SOD Mimetic Activities of Copper(II) Complexes Derived from Methoxybenzylamine Schiff Base Ligands
Schiff base ligands prepared from salicylaldehyde and 2-, 3- and 4-methoxybenzylamine were used to prepare copper(II) complexes, characterized by spectral methods, elemental analysis and X-ray crystallography in the case of complex 4a derived from 2-methoxybenzylamine. The DNA cleavage activity of the prepared complexes was exceptional, with best activities of over 95% one-strand cleavage for 4c at 3 mM and full double-strand cleavage for complex 4a at 5 mM. Absorption titration studies with ct-DNA revealed good binding constants (at 105 M−1) with a decrease of up to 56% light absorption. Meanwhile, the EB–DNA displacement method and viscosity studies revealed groove binding as a possible binding mode. For BSA binding studies, all three complexes showed KBSA values in the optimal range for reversible BSA binding (104 M−1). The copper(II) complexes showed significant cytotoxic effects (67–96% at 1 mM) in mitochondrial activity monitoring assays. Cytotoxicity was confirmed against cancer cell lines (A549 and HepG2) and HEL cells. The complexes 4a and 4c exhibited high activity against HepG2 cancer cells (IC50 < 22 μM), comparable to cisplatin. The radical scavenging activity was determined by the INT method with the best IC50 for 4c (189 ± 11 μM). Overall, complexes 4a and 4c with a methoxy group in the ortho and para positions show high potential in most determined activities, but mainly as DNA cleavers and as cytotoxic agents with selectivity against HepG2 cells.
- 26 June 2025
- Published by Wiley in European Journal of Inorganic Chemistry
Synthesis, Characterization, and Biological Studies of Novel Salicylatocopper(II) Complexes Containing 1,10‐Phenanthroline
The presented study reports the synthesis, structural characterization, and biological evaluation of four novel dinuclear copper(II) complexes with salicylate derivatives, such as 4‐bromsalicylate ((4‐Br‐Sal)2−), 4‐(trifluoromethyl)salicylate ((4(CF3)‐Sal)2−), 6‐fluorosalicylate ((6‐F‐Sal)2−), and 5‐(2´,4´‐difluorophenyl)‐salicylate/diflunisal (dflu2−) and 1,10‐phenanthroline (phen) as neutral N,N′‐donor ligand: [Cu2(4‐Br‐Sal)2(phen)2] (1), [Cu2(4‐CF3‐Sal)2(phen)2] (2), [Cu2(6‐F‐Sal)2(phen)2] (3), [Cu2(diflu)2(phen)2] (4). The complexes are structurally confirmed via X‐ray crystallography, revealing distorted square‐pyramidal geometries and dimeric arrangements stabilized by hydrogen bonding, and containing various amount of solvent molecules in their secondary structure (1.2 H2O for complex 1, 1.36 H2O for 2, 3.2 H2O·EtOH for 3, 1.6 H2O and/or 4·H2O for 4). UV–vis spectroscopic studies demonstrate their significant interactions with calf thymus DNA (ct‐DNA), suggesting intercalation as the most possible mode of binding. Ethidium bromide displacement and viscosity assays support these findings, highlighting their potential as DNA‐targeting agents. Furthermore, the complexes exhibit moderate superoxide dismutase mimetic activity, and catechol oxidase mimetic studies reveal complex‐specific variations in catalytic turnover rates, with complex 3 achieving the highest efficiency due to its optimal Cu···Cu distance and geometry. The study advances the understanding of copper(II)‐based coordination compounds, emphasizing their structural, biological, and catalytic potentials for applications in bioinorganic chemistry and therapeutics.
- 26 June 2025
- Published by Wiley in European Journal of Inorganic Chemistry
Synthesis, Characterization, and Biological Studies of Novel Salicylatocopper(II) Complexes Containing 1,10‐Phenanthroline
The presented study reports the synthesis, structural characterization, and biological evaluation of four novel dinuclear copper(II) complexes with salicylate derivatives, such as 4‐bromsalicylate ((4‐Br‐Sal)2−), 4‐(trifluoromethyl)salicylate ((4(CF3)‐Sal)2−), 6‐fluorosalicylate ((6‐F‐Sal)2−), and 5‐(2´,4´‐difluorophenyl)‐salicylate/diflunisal (dflu2−) and 1,10‐phenanthroline (phen) as neutral N,N′‐donor ligand: [Cu2(4‐Br‐Sal)2(phen)2] (1), [Cu2(4‐CF3‐Sal)2(phen)2] (2), [Cu2(6‐F‐Sal)2(phen)2] (3), [Cu2(diflu)2(phen)2] (4). The complexes are structurally confirmed via X‐ray crystallography, revealing distorted square‐pyramidal geometries and dimeric arrangements stabilized by hydrogen bonding, and containing various amount of solvent molecules in their secondary structure (1.2 H2O for complex 1, 1.36 H2O for 2, 3.2 H2O·EtOH for 3, 1.6 H2O and/or 4·H2O for 4). UV–vis spectroscopic studies demonstrate their significant interactions with calf thymus DNA (ct‐DNA), suggesting intercalation as the most possible mode of binding. Ethidium bromide displacement and viscosity assays support these findings, highlighting their potential as DNA‐targeting agents. Furthermore, the complexes exhibit moderate superoxide dismutase mimetic activity, and catechol oxidase mimetic studies reveal complex‐specific variations in catalytic turnover rates, with complex 3 achieving the highest efficiency due to its optimal Cu···Cu distance and geometry. The study advances the understanding of copper(II)‐based coordination compounds, emphasizing their structural, biological, and catalytic potentials for applications in bioinorganic chemistry and therapeutics.
- Open Access
Bipyridine Ruthenium(II) Complexes with Halogen-Substituted Salicylates: Synthesis, Crystal Structure, and Biological Activity
Ruthenium complexes currently represent a perspective subject of investigation in terms of potential anticancer therapeutics. Eight novel octahedral ruthenium(II) complexes are the subject of this article. Complexes contain 2,2′-bipyridine molecules and salicylates as ligands, differing in position and type of halogen substituent. The structure of the complexes was determined via X-ray structural analysis and NMR spectroscopy. All complexes were characterized by spectral methods—FTIR, UV–Vis, ESI-MS. Complexes show sufficient stability in solutions. Therefore, their biological properties were studied. Binding ability to BSA, interaction with DNA, as well as in vitro antiproliferative effects against MCF-7 and U-118MG cell lines were investigated. Several complexes showed anticancer effects against these cell lines.
Open AccessBipyridine Ruthenium(II) Complexes with Halogen-Substituted Salicylates: Synthesis, Crystal Structure, and Biological Activity
Ruthenium complexes currently represent a perspective subject of investigation in terms of potential anticancer therapeutics. Eight novel octahedral ruthenium(II) complexes are the subject of this article. Complexes contain 2,2′-bipyridine molecules and salicylates as ligands, differing in position and type of halogen substituent. The structure of the complexes was determined via X-ray structural analysis and NMR spectroscopy. All complexes were characterized by spectral methods—FTIR, UV–Vis, ESI-MS. Complexes show sufficient stability in solutions. Therefore, their biological properties were studied. Binding ability to BSA, interaction with DNA, as well as in vitro antiproliferative effects against MCF-7 and U-118MG cell lines were investigated. Several complexes showed anticancer effects against these cell lines.
- 24 June 2020
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 44 (29) , 12827-12842
Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
Reactions of non-steroidal anti-inflammatory drugs tolfenamic (Htolf), meclofenamic (Hmeclf), mefenamic (Hmef), clonixic (Hclon) and niflumic (Hnif) acids with isonicotinamide (isn) and copper(II) acetate resulted in the formation of five novel mixed-ligand Cu(II) coordination compounds: [Cu(tolf-O,O′)2(isn-N)2] (1), [Cu(meclf-O,O′)2(isn-N)2] (2), [Cu(mef-O,O′)2(isn-N)2] (3), [Cu(clon-O,O′)2(isn-N)2] (4), and [Cu(nif-O,O′)2(isn-N)2] (5). The structures of the complexes were determined by single-crystal X-ray analyses. The monomeric complexes build up 1D chains or 2D hydrogen bonding supramolecular networks. The intermolecular interactions were studied by Hirshfeld surface analysis. The redox properties of the complexes were studied by cyclic voltammetry. Cu redox cycling was documented by UV-vis and EPR spectroscopy. Formation of free radicals was monitored by the EPR trapping technique using a DMPO spin trap in a Fenton-like system. Evidence of reduction of the Cu(II) ions upon reaction with O2˙− was obtained using a specific chelator of Cu(I), neocuproine. The interaction of the complexes with bovine serum albumin was studied by fluorescence emission spectroscopy and the binding constants of the compounds to the albumin were calculated. The interaction of the complexes with calf-thymus DNA was monitored by diverse techniques (UV-vis spectroscopy, cyclic voltammetry, viscosity measurements) suggesting intercalation as the most possible mode of binding. DNA-competitive studies of the complexes with ethidium bromide were monitored by fluorescence emission spectroscopy.
- 24 June 2020
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 44 (29) , 12827-12842
Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
Reactions of non-steroidal anti-inflammatory drugs tolfenamic (Htolf), meclofenamic (Hmeclf), mefenamic (Hmef), clonixic (Hclon) and niflumic (Hnif) acids with isonicotinamide (isn) and copper(II) acetate resulted in the formation of five novel mixed-ligand Cu(II) coordination compounds: [Cu(tolf-O,O′)2(isn-N)2] (1), [Cu(meclf-O,O′)2(isn-N)2] (2), [Cu(mef-O,O′)2(isn-N)2] (3), [Cu(clon-O,O′)2(isn-N)2] (4), and [Cu(nif-O,O′)2(isn-N)2] (5). The structures of the complexes were determined by single-crystal X-ray analyses. The monomeric complexes build up 1D chains or 2D hydrogen bonding supramolecular networks. The intermolecular interactions were studied by Hirshfeld surface analysis. The redox properties of the complexes were studied by cyclic voltammetry. Cu redox cycling was documented by UV-vis and EPR spectroscopy. Formation of free radicals was monitored by the EPR trapping technique using a DMPO spin trap in a Fenton-like system. Evidence of reduction of the Cu(II) ions upon reaction with O2˙− was obtained using a specific chelator of Cu(I), neocuproine. The interaction of the complexes with bovine serum albumin was studied by fluorescence emission spectroscopy and the binding constants of the compounds to the albumin were calculated. The interaction of the complexes with calf-thymus DNA was monitored by diverse techniques (UV-vis spectroscopy, cyclic voltammetry, viscosity measurements) suggesting intercalation as the most possible mode of binding. DNA-competitive studies of the complexes with ethidium bromide were monitored by fluorescence emission spectroscopy.
- 31 May 2020
- Published by Springer Nature in Chemical Papers
- Vol. 74 (11) , 3727-3740
Hydrogen bonding supramolecular networks of copper(II) 2-choronicotinate complexes with picolinamide, nicotinamide, N-methyl-nicotinamide, 2-pyridylmethanol and 4-pyridylmethanol: Hirshfeld surface analysis and spectral properties
- 31 May 2020
- Published by Springer Nature in Chemical Papers
- Vol. 74 (11) , 3727-3740
Hydrogen bonding supramolecular networks of copper(II) 2-choronicotinate complexes with picolinamide, nicotinamide, N-methyl-nicotinamide, 2-pyridylmethanol and 4-pyridylmethanol: Hirshfeld surface analysis and spectral properties
- Open Access
- 1 April 2018
- Published by Walter de Gruyter GmbH in Acta Chimica Slovaca
- Vol. 11 (1) , 21-25
Nitrosalicylatocopper(II) complexes with chelating pyridine derivatives
Three new nitrosalicylatocopper(II) complexes have been prepared and characterized. Compounds of the composition Cu(5-NSal) 2 (2-ampy) 2 (1), Cu(5-NSal) 2 (2-hmpy) 2 (2) and Cu(3,5-DNSal) 2 (2-hmpy) 2 (3), where 2-ampy = (2-aminomethyl)pyridine, 2-hmpy = (2-hydroxymethyl)pyridine, 5-NSal = 5-nitrosalicylate anion and 3,5-DNSal = 3,5-dinitrosalicylate anion, were characterized by elemental analyses, EPR and IR spectroscopy. EPR spectra are consistent with the dx 2-y2 ground electronic state. Spectral properties have shown “classic” monodentate coordination of 5-nitrosalicylate anion. Similarly, bonding mode of the 3,5‑dinitrosalicylate anion in (3) is assumed to be unidentate via the carboxyl group, which is surprising compared with the previously studied complex, where the preferred coordination via the phenolate group anion was observed.
- 1 April 2018
- Published by Walter de Gruyter GmbH in Acta Chimica Slovaca
- Vol. 11 (1) , 21-25
Open AccessNitrosalicylatocopper(II) complexes with chelating pyridine derivatives
Three new nitrosalicylatocopper(II) complexes have been prepared and characterized. Compounds of the composition Cu(5-NSal) 2 (2-ampy) 2 (1), Cu(5-NSal) 2 (2-hmpy) 2 (2) and Cu(3,5-DNSal) 2 (2-hmpy) 2 (3), where 2-ampy = (2-aminomethyl)pyridine, 2-hmpy = (2-hydroxymethyl)pyridine, 5-NSal = 5-nitrosalicylate anion and 3,5-DNSal = 3,5-dinitrosalicylate anion, were characterized by elemental analyses, EPR and IR spectroscopy. EPR spectra are consistent with the dx 2-y2 ground electronic state. Spectral properties have shown “classic” monodentate coordination of 5-nitrosalicylate anion. Similarly, bonding mode of the 3,5‑dinitrosalicylate anion in (3) is assumed to be unidentate via the carboxyl group, which is surprising compared with the previously studied complex, where the preferred coordination via the phenolate group anion was observed.